COMMUNIQUÉS West-GlobeNewswire
-
IBA – Information Réglementée
14/07/2026 -
IBA – Regulated information
14/07/2026 -
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
14/07/2026 -
TAP Sleep Care Highlights Breakthrough Case Study on myTAP® Oral Appliance in Journal of Dental Sleep Medicine: Dramatic Two-Night Improvement in Treatment-Resistant OSA
14/07/2026 -
Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)
14/07/2026 -
React19 Applauds Introduction of the Vaccine Injury Compensation Modernization Act of 2026
14/07/2026 -
Arizona Nonprofit Launches "Ultimate Road Trip" Fundraiser Inspiring Families to Make Memories While Funding Childhood Blindness Research
14/07/2026 -
Medicana Health Group Opens Belgrade Liaison Office to Strengthen Its Presence in the Balkans
14/07/2026 -
Aeroflow Sleep Donates to Beds for Kids and Project Sleep to Improve Sleep Health Equity
14/07/2026 -
XOMA Royalty Announces Closing of Its Acquisition by Ligand
14/07/2026 -
ASPN 2026 to Feature Three Abstracts on SPRINT® PNS
14/07/2026 -
AscellaHealth Named ACAP Preferred Vendor to Advance Specialty Pharmacy Strategy, Cost Containment and Care Management
14/07/2026 -
Guardian Initiative Seeks Community and Corporate Sponsors Ahead of September 28 Charity Golf Tournament Benefiting Military, Veterans, First Responders, and Their Families
14/07/2026 -
Applied Biologics Announces Successful Manufacture of First Research Construct for Disease-Modifying Osteoarthritis Gene Therapy Program
14/07/2026 -
SRX Global Reports Paper-Traded EMJX Return of ~25% Since February 11, 2026
14/07/2026 -
Organic & Natural Health Association and India's SHEFEXIL Establish Strategic Partnership to Strengthen U.S.-India Supply Chain
14/07/2026 -
Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease
14/07/2026 -
Ernexa Therapeutics CEO Corner Highlights Differentiated ERNA-101 Platform as Company Advances Toward Planned First-in-Human Phase 1 Study in 2026
14/07/2026 -
Dandy Unveils Polychromatic Shade™ to End the Trade-Off Between Dental Aesthetics and Affordability
14/07/2026
Pages